Idexx Laboratories IDXX Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's other accrued liabilities?
- Idexx Laboratories (IDXX) reported other accrued liabilities of $112.45M in Q1 2026.
- How has Idexx Laboratories's other accrued liabilities changed year-over-year?
- Idexx Laboratories's other accrued liabilities decreased by 33.7% year-over-year, from $169.54M to $112.45M.
- What is the long-term trend for Idexx Laboratories's other accrued liabilities?
- Over 5 years (2020 to 2025), Idexx Laboratories's other accrued liabilities has grown at a 0.3% compound annual growth rate (CAGR), from $112.53M to $114.33M.